Author:
Desai Sheena,Lo Kelly,Nambudiri Vinod E.,Villa-Ruiz Camila,LaChance Avery,Vleugels Ruth Ann
Publisher
Springer Science and Business Media LLC
Subject
Dermatology,General Medicine
Reference6 articles.
1. Gilhar A, Etzioni A, Paus R (2012) Alopecia areata. N Engl J Med 366(16):1515–1525
2. Strazzulla LC, Wang EH, Avila L et al (2018) Alopecia areata: an appraisal of new treatment approaches and overview of current therapies. J Am Acad Dermatol 78(1):15–24
3. Crispin MK, Ko JM, Craiglow BG et al (2016) Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata. JCI Insight 1:15
4. Almutairi N, Nour TM, Hussain NH (2019) Janus kinase inhibitors for the treatment of severe alopecia areata: an open-label comparative study. Dermatology 235(2):130–136
5. Jabbari A, Sansaricq F, Cerise J et al (2018) An open-label pilot study to evaluate the efficacy of tofacitinib in moderate to severe patch-type alopecia areata, totalis, and universalis. J Invest Dermatol 138(7):1539–1545
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献